Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +734.12%
#3 ADO Protocol ADO Protocol +101.66%
#4 Cortex Cortex +93.48%
#5 Ontology Gas Ontology Gas +74.08%
#6 Kinesis Silver Kinesis Silver +53.91%
#7 Magma Finance Magma Finance +27.64%
#8 OpenEden OpenEden +26.06%
#9 PondCoin PondCoin +25.14%
#10 QuantixAI QuantixAI +23.16%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Circio Holding ASA Circio Holding ASA

Circio Holding ASA

CRNA
Rank in Stocks #18608
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Share Price
$0.88044964
Last synced: 2026-07-31
Market Cap
$192.54M
Change (1 day)
-0.71%
Change (1 year)
1,362.12%
Country
NO
Trade Circio Holding ASA (CRNA)

Category

Healthcare
Number of shares outstanding for Circio Holding ASA (CRNA)
Number of shares outstanding as of August 2026: 0
According to Circio Holding ASA latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Circio Holding ASA (CRNA) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH